Heart Shield
| Online Pharmacy: | Minimal Price: | Best Buy: | Shipping: | Payment | Delivery to: |
|---|---|---|---|---|---|
| medixresources | Not available for sale | 14/free |      | most countries | |
| tl-pharmacy | Not available for sale | 10-21 days/free |    | every country | |
| medrx-one | Not available for sale | 10 days/free | | most countries | |
| leadmedic | Not available for sale | 14-21days/$10
5-7 days/$25 | | every country | |
| Medph | Not available for sale | FedEx next day/$24 |  | USA only | |
| med-pen "Heart Shield" | 400mg | 14-20 days/$10
7-14 days/$20 |   | most countries | |
| 10 Pills $31 | 90 Pills $206.1 | ||||
|
All prices (expand / collapse)
|
|||||
| ourpharmacyrx "Heart Shield (Heart Disease)" | 400 mg | 14-21 days/$15
5-12 days/$30 | | most countries | |
| 30 pills $126.9 | 90 pills $288.9 | ||||
|
All prices (expand / collapse)
|
|||||
| RxPharms | Not available for sale | 14-24 days/free | | worldwide | |
| RxMedShop | Not available for sale | 8-16 days/$20
5-9 days/$30 3-6 days/$40 | | most countries | |
BEAT HEART DISEASE WITHOUT SURGERY: EXAMINING THE EFFECTS-CRITICS OF CHELATION AND WHAT THEY SAY-PART 2
In fact there are studies which indicate that chelation therapy actually improves kidney function. This may centre around the fact that unwanted calcium deposits collect in the kidneys (kidney stones) as elsewhere in the body, and EDTA may act to disperse these. Or it may be because kidney function itself depends on ideal levels of blood pressure operating and if this is compromised by the high blood pressure so often seen in arterial disease then kidney function is also compromised. So, redress arterial disease and you stand to improve kidney function, not compromise it.
The criticism that heavy metals circulate through the body during the 24 hours that it takes for them to be chelated out of it is best answered by looking at the alternative: leaving them where they are. At the moment, it is known that heavy metals are deadly poisons and create havoc with cell metabolism, besides prompting free radical activity.
The problems of pollution such as that of lead in petrol are comparatively recent, but studies of individuals living close to fairly busy roads have revealed levels of lead, two or three times those recorded in rural areas.
It is not known at what level lead becomes a serious threat to the immune system, since this would vary between individuals, depending on other factors such as general health, lifestyle, diet, stress, etc. But in 1972 (twenty years ago and automobile traffic has multiplied ten times since then), Dr W. Blumer reports that out of a study of 232 adults living ‘in the immediate vicinity of an automobile road, 11 per cent had died of cancer during the period of observation, 1959 to 1970. This percentage was nine times higher than that observed in a traffic-free region of the same community.’
The report goes on to say that the symptoms preceding the onset of cancer (headaches, fatigue, stomach and intestinal ailments, depression) were mostly alleviated in those residents who were treated with EDTA therapy. As the amount of delta-aminoaevulinic acid in their urine (an early indication of lead poisoning) receded, so did their symptoms.
Reconsidering that EDTA and anything it chelates from the body is effectively excreted within the first 24 hours after the treatment, the risk, even if valid, would seem to be extremely slight in terms of benefits – a risk far far lower than crossing a busy road junction – or having bypass surgery.
The allegation that EDTA, in removing unwanted minerals from the body may also remove wanted minerals, is reasonable. Firstly chelation therapists have always recognized this as a possibility and have safeguarded against it by providing mineral supplements during the chelation course. However evidence is mounting as the years go by that EDTA is selective in its stripping of metals, only stripping metals where they are unbeneficially placed.
Research pertaining to this effect largely centres on calcium, since its interference in cellular activity in artery walls and its presence in arterial plaque have been witnessed for some time. Concern has always centred around the possibility that whilst EDTA leached calcium from arterial walls, it might also leach it from bones or teeth.
In fact several studies have shown the opposite to be the case. It is only the
inappropriately-sited ionic calcium which EDTA acts upon, not calcium bound in bones or teeth. In fact, due to the removal of the ionic calcium and subsequent (temporary) drop of blood levels of calcium, the entire calcium metabolic process is stimulated in much the same way as eating is stimulated by hunger.
The specific result is thought to be stimulation of the parathyroids, which produce parahormone which in turn prompts the formation of bone matter. This process has been described by researchers such as Rasmussen and Bordier (1974), and followed up by Cranton and Brecher (1984) who were interested in finding out why those who had chelation continued to improve and add bone for at least three months after the treatment had ended. The production of osteoblasts (bone cells) was shown to be heightened for this duration. (My own bone-scan test results confirm this – a 3 per cent increase in bone after 17 chelation treatments.)
Attention must also be drawn to a recent study (done in 1993) whose findings are not as yet published but will be by the time this book goes to press. Conducted by a leading Netherlands research organization (IWO-TNO) it examined, among other factors, the excretion of heavy metals brought about during chelation therapy and noted the interesting phenomenon that although zinc, a vital metal for health, was excreted along with unwanted lead, cadmium and iron, levels of zinc in patients undergoing chelation actually rose as the therapy proceeded. Thus a regulatory mechanism seemed to have been stimulated.
Cardio & Blood He went on to say, ‘That sort of general criticism without scientific support is typical of our critics, who can’t prove their negative view of EDTA but ask me to prove my positive view in each and every way.’
And in any case treatment risk, whatever it may be – and evidence points to it being very much less than that of bypass surgery, drugs or angioplasty – must be weighed against the severity of the illness, in many cases life-threatening, for which the treatment is being given. That point seems to have escaped everyone. No treatment is without some risk, however slight.
*43/104/2*
